Increasing evidences have indicated that CSCs contribute to NSCLC tumor initiation, malignant progression, metastasis, and therapy resistance through modulating multiple mechanism, including TGF-β/TGF-βR signaling pathway and TGF-β/TGF-βR signaling pathway [14, 15]. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.